The RIG-I-induced inhibition of Akt activation was shown to contribute to RIG-I’s negative regulation of oncogenic cytokine-stimulated proliferation of primary myeloid progenitors and also to its negative regulation of in vivo maintenance of leukemia stemness [5]. The gene discussed is RIGI; the disease is leukemia.